The male god of magic capital

Chengtian Holdings, the president's office, Luo Cheng was very happy after seeing so many comments, and there is no need to worry about the expansion of Huaxia Chengtian Mixed Fund.

As long as the performance is stable, he believes that many Christians who have bought other funds will choose to buy the fund of Chengtian Holdings.

Those public funds that usually perform well will perform very badly when the stock market plummets, and their net worth will shrink severely. However, Chengtian public funds are different, stable!
To be honest, Luo Cheng hopes that the A-shares will plummet a few more times, so that these greedy Christians will realize what "stableness" is. It is not enough to be greedy for high returns. To buy those high-risk funds, it is better to buy Chengtian Funds under Hybrid Vanguard.

At present, the Chengtian Public Fund Management Department has also taken shape. The medical and biological fund under Huaxia Chengtian Mixed Pioneer has a scale of 1100 billion, which is managed by professional traders in the medical and biological group.

Now that private equity funds and public equity funds have been secured, Luo Cheng doesn't have to worry about it anymore.

The next thing is to hand it over to the team.

The traders of Chengtian Holdings are all high-achieving students from Fudan University. Proprietary traders and future fund managers are all traders trained internally by Chengtian Holdings and will not recruit externally.

Traders are assessed every day, and excellent traders are selected every week and every month. Those who are eliminated can only be reduced to operators and do not have the qualifications to become self-operated traders. Only after passing the assessment can they become self-operated traders. Traders, this self-operated trader can operate the funds provided by the company, and the profits can be shared, and the income will be very high.

Of course, Chengtian Holdings has not provided self-operated funds yet, and will provide self-operated funds in the future to allow excellent self-operated traders to operate.

But it is not so easy to train an excellent self-operated trader, and it may cost a lot of money. After all, many traders have lost money, and the company has to pay for their loss costs, so the risk control department It is extremely important.

Jiang Ning came over and asked: "BOSS, many old customers are now asking our customer service, when will the subscription open, or set up sub-funds for other sectors?"

At present, Chengtian Mixed Pioneer has a medical and biological fund, which is responsible for the medical and biological sector. It has issued 1000 billion funds. The original price of each share is 1 yuan. At present, each share is worth 1.1 yuan. The subscription channel is currently closed. These old customers want to continue to subscribe, but they have no shares.

Luo Cheng thought for a while and said, "Let's talk about it later, the stock market isn't very good, and if you have too much money, it's just for nothing."

The medical and biological sector has already invested 1000 billion yuan, which is enough. Luo Cheng has not yet decided which sector to work on, the automobile sector, the military sector, and the food and wine sector?

Luo Cheng hasn't figured out which section to work on next.

Now Chengtian Private Equity Fund and Chengtian Mixed Pioneer don't need Luo Cheng to do it himself, and the next step is the Luo Family Foundation.

In the A-share account, there are 6 million yuan, and the "Chengtian Manor" is still under construction, and 6 million yuan will be paid for the project in the mid-term, and 10 billion yuan will be paid to Sunshine Real Estate Group when it is completed.

In the Hong Kong stock market, there is still 10 billion Hong Kong dollars in funds. This is Luo Cheng's funds in Xiangjiang. , only 10 billion Hong Kong dollars.

Later, when Cheng Tian Holdings went to Xiangjiang, it would need a lot of Hong Kong dollars. Luo Cheng planned to use the Hong Kong dollars owned by the Luo Family Foundation to acquire 75% of the equity of a large financial company, and then let Cheng Tian Holdings directly acquire it, directly Listed in two places.

"Next, choose an A-share and a Hong Kong stock to operate."

Then Luo Cheng picked stocks.

Semiconductor sector, food and wine sector, military sector, communication sector...
At night, I still haven't found a suitable one.

The next day, Saturday, I finally returned to the medical and biological sector to choose stocks.

Pien Tze Huang?

Forget it, it's been done before.

El Ophthalmology?

No, it will have a limited increase in the future.

Rejuvenation medicine?

It is not suitable for Fuxing Medicine to compete with Shenzhou Baekje Biological Company.

Zhifei Bio, Hengrui Medicine, WuXi AppTec, Mindray Medical?
Forget it, the market value is too high. When it more than doubles, I don’t know when it will be. Luo Cheng’s A-share account only has 5 million funds. If you want to rise fast, the market value is medium-sized, 5 million Even if you go in, you can't make any big waves.

Unfortunately, no suitable stock could be found.

In the Whampoa trading group.

Nirvana in stock trading: "Last year, a company went public in the medical sector, called Kanglong Chemical. Since its listing, its stock price has risen from 9 yuan to the current 36 yuan, a four-fold increase in a year. I am very optimistic about its prospects. , what do you think?"

Dropped out of school to speculate in stocks: "Old Zhou, Pharmaron Chemicals has already risen by 4 times, do you still think it can continue to skyrocket?"

Stock Nirvana: "Of course, I am very optimistic about its prospects, you can check it out."

Stocks to support the family: "I checked just now, and the fundamentals are good, but it is a bit difficult for the stock price to continue to double."

Pharmaron Chemicals is a high-tech medical enterprise, with more than 51% of its employees having doctors and masters. It is the largest drug research and development service organization in the northern region of the CRO industry in China. The research and development fields mainly focus on the organic synthesis of small molecules of drugs, medicinal chemistry, and analytical chemistry. , R&D biology, drug metabolism and kinetics, bioanalysis, pharmaceutical process research and development and production, pathological toxicology, etc., involving all aspects of preclinical research and development of new drugs, is the first company in China to have preclinical toxicology in line with European and American GLP A CRO company with service capabilities.

Now the stock price is 36 yuan per share, the total share capital is 12 billion shares, and the market value is as high as 432 billion. However, it is still listed in two places. It is listed on A shares and Xiangjiang at the same time.

Luo Cheng said in the group chat: "Let's get together and see how to operate it."

So, in the evening, everyone came to the tea house of Binjiang Xinjing Hotel in Modu.

Drinking top-quality Longjing tea, everyone discussed the stock of Kanglong Huacheng.

Ling Guangchang said: "The major shareholder behind Kanglong Chemical is a private equity fund called Dashuai Assets, with a scale of more than 1500 billion. The founder is Peng Shuxiang!"

"This Marshal Asset holds 15% of Pharmaron's equity."

"The founders still hold 10% of the shares because of multiple financing mergers and acquisitions, and they control the company together."

"Among them, Tianhai Fund holds 5%, Lion Fund holds 4%, and Jardine Fund holds 3%, adding up to 12%."

"Tianhai Fund, Nuoan Fund, and Jardine Fund have given a lot of orders after they took a stake in Kanglong Chemical. Currently, Kanglong Chemical is also cooperating with Shenzhou Baekje."

"Now Tianhai Fund, Lion Fund, Jardine Fund, and the co-founders are constantly cutting off the interests of Dashuai's assets in Kanglong."

Zhou Yuanping: "Male god, your enemy Wu Tianhai is really vicious, and he wants to kick the commander-in-chief out of the game."

Zhang Hanlin: "This Dashuai asset funded Kanglong Huacheng before the listing of Kanglong Huacheng. It belongs to an investor. Now it is at odds with the founder, and the three parties check and balance each other."

Ling Guangchang: "Peng Shuxiang of Dashuai Assets intends to reduce his holdings of Kanglong Huacheng. I think this Dashuai Assets also wants to withdraw. How about we take over some of the stocks held by Dashuai Assets?"

Luo Cheng thought for a while and said, "The stock price of Kanglong Chemical is still falling. We can first ask Peng Shuxiang if he is willing to sell the stock!"

"If you don't want to, we will buy it in the market, and then combine the assets of the commander in chief to check and balance Wu Tianhai's side."

"it is good!"

"Then buy it on the secondary market!"

"We don't have much money anyway!"

The next day, Sunday, Luo Cheng directly called Peng Shuxiang of the Marshal Assets and asked him if he would like to sell part of the shares of Pharmaron Chemicals.

When Peng Shuxiang heard this, he immediately changed his mind: "Mr. Luo, do you plan to hold the shares of Pharmaron for a long time?"

Luo Cheng: "Not necessarily."

Peng Shuxiang thought for a while and said: "I hold Hong Kong stocks, and I plan to cash out 40 billion Hong Kong dollars. The premium is 10%. Do you want it?"

Luo Cheng: "I can't afford it with small funds. If the discount is 15%, I will buy 10 billion Hong Kong dollars."

"Mr. Luo, the premium is 10%!" Peng Shuxiang said, "In the future, Kanglong Chemical's stock price will definitely continue to rise. Its stock price has plummeted recently because Wu Tianhai's people are washing the market."

Luo Cheng: "Forget it, I'll buy it on the secondary market!"

Peng Shuxiang: "Well, Mr. Luo can buy it in the secondary market. In fact, I don't have to cash out. After you become a shareholder of Kanglong Huacheng, everyone can cooperate. I know that you have trouble with Wu Tianhai, and I will also He can't get through."

Luo Cheng: "Good!"

On Monday, June 6, the stock market did not continue to rise, but fell.

Pharmaron's share price fell sharply today.

35.41
34.55
33.14
32.00,

31.55
At the closing price on 30.41, Luo Cheng did not make a move, while Ling Guangchang, Zhang Hanlin, Zhou Yuanping and others had put in 2 million each, with an average price of 33 yuan per share.

"I'll go, there are a lot of sales!" Zhou Yuanping couldn't help but sigh.

"Today, there are a lot of establishments, and there are a lot of selling orders in the market!" Zhang Hanlin was a little surprised, why when they were buying the bottom, the transaction volume was particularly large and there were so many selling orders.

Ling Guangchang: "Could it be Peng Shuxiang who is selling?"

"This Peng Shuxiang is holding the Hong Kong stock of Pharmaron Chemicals. Today, the stock price of Pharmaron Chemicals on the A-shares fell sharply."

Luo Cheng: "I don't know about this, let him!"

The next day, Pharmaron's share price continued to fall, falling below 30 yuan per share.

29.11
28.72
At 28.00, Luo Cheng made a move.

BIG BUY!
Forcefully pull up its share price!

28.12
28.32
28.99
29.41
30.45
31.55
At 32.00, I bought 6 million shares and held 2000 million shares of Kanglong Chemicals on the A shares, but not long after Luo Cheng finished sweeping the stock, the stock price fell again.

31.11
30.22
29.41
28.31
·
Luo Cheng had a floating loss on the book, so he ignored it, and directly opened the stock price chart of the Hong Kong stock Pharmaron Chemicals.